Stock CADL CANDEL THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Candel Therapeutics, Inc.

Equities

CADL

US1374041093

Real-time Estimate Cboe BZX
Other stock markets
 02:40:16 2024-05-28 pm EDT 		5-day change 1st Jan Change
8.635 USD +10.71% Intraday chart for Candel Therapeutics, Inc. -28.36% +497.96%
May. 23 Candel Therapeutics Reports Prolonged Overall Survival in Phase 2 Clinical Trial of Can-2409 for Advanced Non-Small Cell Lung Cancer in Patients Non-Responsive to Immune Checkpoint Inhibitor Treatment At 2024 Asco Annual Meeting CI
Apr. 11 Sector Update: Health Care Stocks Decline Thursday Afternoon MT

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

  1. Stock Market
  2. Equities
  3. CADL Stock
  4. Revisions Candel Therapeutics, Inc.